Case Reports
doi: 10.1684/ejd.2013.1929.
Resolution with rituximab of localized scleroderma occurring during etanercept treatment in a patient with rheumatoid arthritis
- PMID: 23557629
- DOI: 10.1684/ejd.2013.1929
Item in Clipboard
Case Reports
Resolution with rituximab of localized scleroderma occurring during etanercept treatment in a patient with rheumatoid arthritis
Eur J Dermatol.
.
No abstract available
Similar articles
-
[Membranous nephropathy secondary to rheumatoid arthritis occurring during anti-TNFalpha therapy and responsive to second-line treatment with rituximab].G Ital Nefrol. 2011 Mar-Apr;28(2):214-8. G Ital Nefrol. 2011. PMID: 21488037 Italian.
-
Cost-effectiveness analysis of rituximab treatment in patients in Germany with rheumatoid arthritis after etanercept-failure.Eur J Health Econ. 2010 Feb;11(1):95-104. doi: 10.1007/s10198-009-0205-y. Epub 2009 Dec 5. Eur J Health Econ. 2010. PMID: 19967426
-
Decrease in the levels of anti-cyclic citrullinated peptide antibody in Japanese patients with rheumatoid arthritis who responded to anti-tumor necrosis factor-α.Mod Rheumatol. 2010 Oct;20(5):528-30. doi: 10.1007/s10165-010-0305-7. Epub 2010 May 12. Mod Rheumatol. 2010. PMID: 20458607 No abstract available.
-
Etanercept and infliximab for rheumatoid arthritis.Drug Ther Bull. 2001 Jul;39(7):49-52. Drug Ther Bull. 2001. PMID: 11471515 Review.
-
Tumor necrosis factor inactivation in the management of rheumatoid arthritis.South Med J. 2000 Aug;93(8):753-9. South Med J. 2000. PMID: 10963503 Review.
Cited by
-
Morphea: The 2023 update.Front Med (Lausanne). 2023 Feb 13;10:1108623. doi: 10.3389/fmed.2023.1108623. eCollection 2023. Front Med (Lausanne). 2023. PMID: 36860340 Free PMC article. Review.
-
Autoantibodies in Morphea: An Update.Front Immunol. 2019 Jul 9;10:1487. doi: 10.3389/fimmu.2019.01487. eCollection 2019. Front Immunol. 2019. PMID: 31354701 Free PMC article. Review.
-
New Challenging Systemic Therapies for Juvenile Scleroderma: A Comprehensive Review.Pharmaceuticals (Basel). 2025 Apr 28;18(5):643. doi: 10.3390/ph18050643. Pharmaceuticals (Basel). 2025. PMID: 40430462 Free PMC article. Review.
-
Development of Morphea Following Treatment with an ADA Biosimilar: A Case Report.Curr Rheumatol Rev. 2024;20(4):451-454. doi: 10.2174/0115733971266803231117072453. Curr Rheumatol Rev. 2024. PMID: 38243962
-
Systemic sclerosis and rheumatoid arthritis overlap syndrome - management of severe cardiac, pulmonary and articular involvement.Reumatologia. 2023;61(1):55-62. doi: 10.5114/reum/161299. Epub 2023 Mar 8. Reumatologia. 2023. PMID: 36998578 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
